These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8226322)

  • 1. Structure-antitumor activity relationship of semi-synthetic spicamycin analogues.
    Kamishohara M; Kawai H; Odagawa A; Isoe T; Mochizuki J; Uchida T; Hayakawa Y; Seto H; Tsuruo T; Otake N
    J Antibiot (Tokyo); 1993 Sep; 46(9):1439-46. PubMed ID: 8226322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activities of glycine-exchanged analogs of spicamycin.
    Sakai T; Kawai H; Kamishohara M; Odagawa A; Suzuki A; Uchida T; Kawasaki T; Tsuruo T; Otake N
    J Antibiot (Tokyo); 1995 Jun; 48(6):504-8. PubMed ID: 7622437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-antitumor activity relationship of semi-synthetic Spicamycin derivatives.
    Sakai T; Kawai H; Kamishohara M; Odagawa A; Suzuki A; Uchida T; Kawasaki T; Tsuruo T; Otake N
    J Antibiot (Tokyo); 1995 Dec; 48(12):1467-80. PubMed ID: 8557605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of SPM VIII, a derivative of the nucleoside antibiotic spicamycin, against human tumor xenografts.
    Kamishohara M; Kawai H; Odagawa A; Isoe T; Mochizuki J; Uchida T; Hayakawa Y; Seto H; Tsuruo T; Otake N
    J Antibiot (Tokyo); 1994 Nov; 47(11):1305-11. PubMed ID: 8002395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protein synthesis inhibitor--antitumor activity and mode of action of KRN 5500].
    Kawai H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1571-7. PubMed ID: 9309156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite.
    Noguchi T; Ichii S; Morisada S; Yamaoka T; Yanagi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1055-60. PubMed ID: 9849585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor septacidin analogues.
    Acton EM; Ryan KJ; Luetzow AE
    J Med Chem; 1977 Nov; 20(11):1362-71. PubMed ID: 915894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
    Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    Hanaoka K; Suzuki M; Kobayashi T; Tanzawa F; Tanaka K; Shibayama T; Miura S; Ikeda T; Iwabuchi H; Nakagawa A; Mitsuhashi Y; Hisaoka M; Kaneko M; Tomida A; Wataya Y; Nomura T; Sasaki T; Matsuda A; Tsuruo T; Kurakata S
    Int J Cancer; 1999 Jul; 82(2):226-36. PubMed ID: 10389757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells.
    Kamishohara M; Kawai H; Sakai T; Isoe T; Hasegawa K; Mochizuki J; Uchida T; Kataoka S; Yamaki H; Tsuruo T
    Oncol Res; 1994; 6(8):383-90. PubMed ID: 7894087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute configuration of spicamycin, an antitumor antibiotic produced by Streptomyces alanosinicus.
    Sakai T; Shindo K; Odagawa A; Suzuki A; Kawai H; Kobayashi K; Hayakawa Y; Seto H; Otake N
    J Antibiot (Tokyo); 1995 Aug; 48(8):899-900. PubMed ID: 7592040
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.
    Hinman LM; Hamann PR; Wallace R; Menendez AT; Durr FE; Upeslacis J
    Cancer Res; 1993 Jul; 53(14):3336-42. PubMed ID: 8324745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent antitumor activity of quinolone compounds with an unsaturated aminoazabicyclo group at the C-7 position of the quinolone ring.
    Arakawa H; Mano E; Hakoda N; Yoshinari T; Nakagawa S; Okura A
    Anticancer Drug Des; 1996 Apr; 11(3):221-9. PubMed ID: 8663909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
    Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of novel C-8 ester derivatives of leinamycin.
    Kanda Y; Ashizawa T; Kawashima K; Ikeda S; Tamaoki T
    Bioorg Med Chem Lett; 2003 Feb; 13(3):455-8. PubMed ID: 12565949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the structure and cytotoxic activity of asterriquinone, an antitumor metabolite of Aspergillus terreus, and its alkyl ether derivatives.
    Kaji A; Saito R; Nomura M; Miyamoto K; Kiriyama N
    Biol Pharm Bull; 1998 Sep; 21(9):945-9. PubMed ID: 9781844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new antitumor antibiotic, FR900840. III. Antitumor activity against experimental tumors.
    Nishimura M; Nakada H; Kawamura I; Mizota T; Shimomura K; Nakahara K; Goto T; Yamaguchi I; Okuhara M
    J Antibiot (Tokyo); 1989 Apr; 42(4):553-7. PubMed ID: 2542208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.